TRINITY BIOTECH PLC (TRIB) — Institutional Holders & Catalysts | BiotechEdge

Catalysts Convergence Squeeze Signals Cash Runway Insiders Research

Home›Companies›TRINITY BIOTECH PLC (TRIB)

TRINITY BIOTECH PLC

TRIB

Held by 1 specialist biotech fund

1 fund opened new positions. Short interest: 1.9% of float.

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

2.2/10

1 fund opened new positions

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Perceptive Advisors

Position history (shares)

Perceptive Advisors

2 quarters

Position Trend

Aug 14, 2025

$1.2M

1 fund

Nov 14, 2025

$1.9M

1 fund

Feb 17, 2026

0 funds

-100% total institutional value over 3 quarters

Short Interest

Short Shares

201K

Change

-18.9%

Days to Cover

0.9

% of Float

1.9%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13D/APerceptive Advisors9.9%Jan 26, 2026

SC 13D/APerceptive Advisors9.9%Dec 23, 2025

SC 13D/APerceptive Advisors22.5%Oct 24, 2025

SC 13D/APerceptive Advisors19.8%Mar 25, 2025

SC 13D/APerceptive Advisors20.9%Feb 14, 2025

Position Details

Perceptive AdvisorsEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

2 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

AAVXF1 fund BLLN1 fund ADMA1 fund AMLX1 fund AQST1 fund XFOR1 fund ACLX1 fund CELC1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer